Right-sided heart failure in acute respiratory distress syndrome

Area of Science:

• Critical care medicine
• Cardiology
• Pulmonology

Background:

• Right-sided heart dysfunction (RHD) is an underappreciated complication in acute respiratory distress syndrome (ARDS).
• Several factors increase right ventricular (RV) afterload in ARDS, including hypoxia, hypercapnia, acidosis, thrombosis, and vascular imbalances.
• Mechanical ventilation, while essential, can exacerbate hemodynamic instability in ARDS patients with RHD.

Purpose of the Study:

• To provide an updated overview of the pathophysiology, diagnosis, and treatment of RHD in ARDS.
• To highlight the systemic implications of RHD in ARDS, such as renal dysfunction and circulatory failure.
• To discuss current and potential therapeutic strategies for ARDS-associated RHD.

Main Methods:

• Review of existing literature on RHD in ARDS.
• Analysis of mechanisms contributing to RV afterload and dysfunction.
• Evaluation of diagnostic approaches including hemodynamic monitoring and imaging.
• Assessment of current and emerging treatment options.

Main Results:

• RHD in ARDS can lead to renal dysfunction and circulatory failure through impaired perfusion and venous congestion.
• Diagnosis requires an integrated approach combining invasive and noninvasive methods.
• Limited specific treatments exist, with positive end-expiratory pressure titration and inhaled vasodilators playing key roles.
• Pharmacological agents like levosimendan and vasoactive drugs show potential but require further study.

Conclusions:

• RHD is a significant contributor to morbidity and mortality in ARDS.
• An integrated diagnostic and management strategy is crucial for ARDS patients with RHD.
• Further large-scale clinical trials are needed to establish effective pharmacologic treatments for ARDS-associated RHD.